-
Recent Posts
Recent Comments
Archives
- January 2011
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- July 2008
- May 2008
- April 2008
- February 2008
- January 2008
- October 2007
- July 2007
- June 2007
- April 2007
- January 2007
- October 2006
- July 2006
- May 2006
- April 2006
- January 2006
- November 2005
- October 2005
- August 2005
- July 2005
- June 2005
- May 2005
- April 2005
- March 2005
- January 2005
- November 2004
- October 2004
- July 2004
- April 2004
- March 2004
- February 2004
- January 2004
- November 2003
- October 2003
- August 2003
- July 2003
- June 2003
- April 2003
- January 2003
- October 2002
- September 2002
- August 2002
- July 2002
- April 2002
- February 2002
- January 2002
- October 2001
- July 2001
- April 2001
- February 2001
- January 2001
- July 2000
- April 2000
- January 2000
- December 1999
- November 1999
- October 1999
- July 1999
- October 1998
- September 1998
- August 1998
- July 1998
Categories
- 26th_District
- 3TIER
- 43rd_district
- Access_Award
- Aculight
- Advanced_Electroluminescent_Sciences
- Advanced_Hardware
- Advanced_Silicon
- Aegis_Biosciences
- Aerospace
- Allez_PhysiOnix
- Alliance_of_Angels
- American_Premix
- American_Semiconductor
- Amplicon
- Andgar
- Angel_Capital_Association
- APEL
- Apples_To_Go
- Applied_Micro_Optics
- Applied_Precision
- Arcadia_Biosciences
- Argo
- ARI_Technologies
- ARRA
- Artemisia_Biomedical
- Assay_Dynamics
- ATL_Ultrasound
- ATS
- Avista
- AWB
- Babak_Parviz
- BandG_Farms
- Barleans_Organic_Oils
- Belhaven
- Bellingham
- Bellingham_Angel_Group
- Bio~OriGyn
- Boeing
- Bothell
- BPA
- Brett_Bros
- Business_Consulting
- Cadwell_Laboratories
- Caldus
- Carbon_Nanoprobes
- Cascade_Quality_Molding
- CellVitro
- Cheatham
- CHROMiX
- Closed
- Columbia_Investor_Group
- Columbia_PhytoTechnology
- CombiMatrix
- Company_and_Client_News
- Cray
- CREDC
- CTED
- CWU
- Daniel_Chiu
- DARPA
- Data_Data
- dB_Systems
- Decagon
- Defense_and_Security
- Dept_of_Commerce
- DiMeMa
- DOE
- Dot_On
- D_A_Instrument
- Efficere
- EKOS
- Enerdyne
- EnerG2
- Energy
- Enertechnix
- Erudite
- Events
- EWU
- federal_government
- Flat_Spin_Media
- Forest_Concepts
- Funding
- Galaxy_Compound
- General_Dynamics
- GenPrime
- GeoMonkey
- Governor
- Greenwood_Technologies
- GWATA
- Harmonics
- Healionics
- Heatcon
- HIT_Lab
- Hochberg
- Hummingbird_Scientific
- Hyperion_Innovations
- HyperLynx
- ID
- Impact_Washington
- Impulse_Accelerated
- Index Report
- Infometrix
- Information_Systems_Laboratories
- InnovaTek
- innovation
- Inova
- Insilicos
- Insitu
- INTEC
- Intellectual_Property
- Intelligent_Ion
- IntelliSense
- inVision_Technology
- IPZs
- IsoRay
- Isotron
- Kronos_Air_Technologies
- LAB/COR
- laboratories
- Lacey
- La_Haye
- Lee_Cheatham
- Legal
- Legislature
- Life_Sciences
- Life_Sciences_Discovery_Fund
- LIPS
- LizardTech
- LumenIQ
- Lygan
- Magic_Wheels
- MCD_Technologies
- McFarland_Cascade
- McKinstry
- Meier_Enterprises
- MEMS_and_Nanotechnology
- MesoSystems
- MicroConnex
- Microfabrication_Lab
- MicroGREEN_Polymers
- Micronics
- Microsoft
- Microvision
- Micro_Encoder
- Mikron
- Mimic
- MITEF
- MNBC
- Modumetal
- Molecular_Kinetics
- Multiform_Harvest
- NanoString_Technologies
- Nanotechnology
- Neah_Power
- New_Light
- New_Light_Industries
- nLIGHT
- Northstar_Neuroscience
- Northwest_Energy_Angels
- Northwest_Marine
- Northwest_Quality_Products
- Northwind_Marine
- NREL
- NSCC
- NTUF
- Nu_Element
- NWEN
- NWETC
- OC_Technologies
- Omax
- Omeros
- ONAMI
- OSU
- Pacific_Research_Laboratories
- Packet_Engines
- Paine_Electronics
- Paroscientific
- Partner_News_and_More
- Pathway_Medical_Technologies
- PhysioSonics
- Pico_Computing
- Plant_Care_Technologies
- PNNL
- Posture_Wings
- PriTest
- Pro-Tech
- QUEST_Integrated
- Quincy_Farm_Chemicals
- Quote-Client
- Quote-Legislator
- Quote-Partner
- Quote-Researcher
- Quote-WTC
- Radiant_Optics
- RationalDiagnostics
- RealNetworks
- Recycled_Plastics_Marketing
- Redmond
- Rhoads
- Richland
- RS_Medical
- RTD
- Saint-Gobain
- SBIR
- Seattle
- Senator Cantwell
- Senator_Murray
- Shoreline_Industries
- Sienna
- Simulab
- Sirti
- Social_Media_Survey
- SoilSoup
- Soliv
- Sonotech
- Sonus
- Southeast
- Southwest
- Spectra_Lux
- Springstar
- SSTI
- Sterling
- Stimulus
- Stratos_Genomics
- StressWave
- Summit
- SuperTel
- Survival
- Syntrix
- Systematix
- TechAmerica
- TechFlash
- Technology_Alliance
- Theo_Chocolate
- Therus
- TraceDetect
- Tree_Top
- TREN
- Ultreo
- Uncategorized
- UNIBEST
- University_of_Oregon
- US_Commerce
- US_EDA
- UW
- UW TechTransfer
- UW_Center_for_Commercialization
- UW_Center_for_Innovation_and_Entrepreneurship
- UW_Center_for_Nanotechnology
- Vaagen_Brothers
- Vancouver
- Vancouver_User_Facility
- Vanson
- VentriPoint
- Vipin_Kumar
- VirtuSphere
- VisionGate
- Vista_Engineering
- VizX_Labs
- Voxtel
- Washington
- Washington_Farms
- Washington_Global_Health_Alliance
- WBBA
- WEDC
- WINGS
- WNI
- Woodinville
- WSIB
- WSU
- WTC_Angel_Network
- WTC_News
- WTIA
- Xconomy
- YK_Products
- Zeus_Semiconductor
- Zino_Society
Meta
Category Archives: Omeros
Washington companies win $34 million in Therapeutic Discovery Project Grants
Washington life sciences companies won more than $34 million in grants through the U.S. Internal Revenue Service under the Qualifying Therapeutic Discovery Project Program which was created by the Affordable Care Act. The grant covers up to 50 percent of … Continue reading
Life Sciences Discovery Fund to start new initiative with Omeros proceeds
Washington’s Life Sciences Discovery Fund (LSDF) announced “a $5 million grant to Seattle-based Omeros Corporation to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of … Continue reading
Omeros gains $20M from Vulcan and $5M from Life Sciences Discovery Fund
Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, announced “that it has received $20 million from Vulcan Capital (Vulcan) and a grant award for $5 million from Washington State’s Life Sciences Discovery Fund (LSDF) to support the advancement of the Company’s … Continue reading
Omeros addiction program study wins $3.6M federal grant
Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, announced that the National Institute on Drug Abuse (part of the NIH) has provided an additional grant — $3.6 million over four years — to fund clinical studies for the company’s addiction program. … Continue reading
Posted in Company_and_Client_News, Funding, Life_Sciences, Omeros
Leave a comment
Omeros receives support for clinical study from National Institute on Drug Abuse
Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, announced that “the National Institute on Drug Abuse (NIDA) is providing support for the Company’s Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be … Continue reading
Posted in 43rd_district, Company_and_Client_News, Funding, Life_Sciences, Omeros, RTD, Seattle
Leave a comment
Washington Technology Center awards $394,910 to spur innovation and jobs
Four University of Washington researchers have been awarded state funding for partnerships with Washington companies developing innovative commercial technologies. SEATTLE — January 4, 2010 — Washington Technology Center has awarded a total of $394,910 in state funding to four University … Continue reading
Omeros stock IPO closes lower in first two days of trading
Omeros Corporation, a Seattle-based biopharmaceutical company, saw its stock price close lower in its first two days of trading after the company’s initial public offering (IPO) on October 8, 2009. The company had priced its offering of 6.82 million shares … Continue reading
Posted in 43rd_district, Company_and_Client_News, Funding, Life_Sciences, Omeros, RTD, Seattle
Leave a comment
Washington Technology Center Awards $485,261 in Research Funding
Washington Technology Center awarded research and technology development funding totaling $485,261 to seven* projects developed between companies and Washington researchers. Companies with winning projects for January 2009 are: Applied Precision, of Issaquah; ATS, of Silverdale; The Boeing Company and HEATCON® … Continue reading
Posted in Applied_Precision, ATS, Boeing, Company_and_Client_News, Enertechnix, Funding, GeoMonkey, Heatcon, Omeros, RTD, Theo_Chocolate, WTC_News
Leave a comment
Omeros awarded $465,000 grant for Parkinson’s research
Omeros Corporation, a Seattle-based biopharmaceutical company, has been awarded a $465,000 grant from The Michael J. Fox Foundation to evaluate Omeros’ recent dicovery of a new target for the treatment of Parkinson’s disease. Related external links (will open a new … Continue reading
Posted in 43rd_district, Company_and_Client_News, Funding, Life_Sciences, Omeros, RTD, Seattle
Leave a comment
Washington Technology Center Awards $528,978 in Research Funding
Eight company-researcher projects have been awarded state funding for the development of innovative commercial technology applications. Seattle, WA — January 14, 2008 — Washington Technology Center awarded Research and Technology Development funding totaling $528,978 to eight projects developed between companies and Washington … Continue reading
Posted in ATS, Columbia_PhytoTechnology, Efficere, Funding, Greenwood_Technologies, Infometrix, Insilicos, nLIGHT, Omeros, RTD, WTC_News
Leave a comment